Skip to main content
. 2018 Jan 12;14:135–147. doi: 10.3762/bjoc.14.9

Table 3.

In vitro antibacterial, antifungal and cytotoxic activity of compounds 9, 14 and 17 in comparison with positive controls.

Test organism 9a 14a 17a Reference

Fungi

Candida albicans DSM 1665 16.6 33.3b
Mucor hiemalis DSM 2656 33.3 16.6 5.25–16.6b
Pichia anomala DSM 70255 33.3 33.3b
Rhodotorula glutinis DSM 10134 16.6 0.52–16.7b
Schizosaccharomyces pombe DSM 70572 16.6 42.0–67.0b

Bacteria

Bacillus subtilis DSM 10 67.0 6.7–8.3c
Chromobacterium violaceum DSM 30191 67.0 0.83–8.3c
Escherichia coli DSM 1116 0.83c
Micrococcus luteus DSM 20030 0.42c
Mycobacterium sp. DSM 43270 2.1c
Pseudomonas aeruginosa DSM 50071 16.6–21.0d
Staphylococcus aureus DSM 346 67.0 0.1–0.21c
Eukaryotic cell line
Murine cell line L929 >10 6 >10 1 nme

aFor compound testings against bacteria and fungi minimum inhibitory concentrations (MIC) in μg mL−1 are given, for cytotoxicity testings against the murine cell line the IC50 is given in μg mL−1. Reference compounds: bnystatin, coxytetracyclin hydrochloride, dgentamycin, eepothilon B.